Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer

Our previous work demonstrates that DHX32 is upregulated in colorectal cancer (CRC) compared to its adjacent normal tissues. However, how overexpressed DHX32 contributes to CRC remains largely unknown. In this study, we reported that DHX32 was overexpressed in human colon cancer cells. Overexpressed...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 5; no. 1; p. 9247
Main Authors Lin, Huayue, Liu, Wenjuan, Fang, Zanxi, Liang, Xianming, Li, Juan, Bai, Yongying, Lin, Lingqing, You, Hanyu, Pei, Yihua, Wang, Fen, Zhang, Zhong-Ying
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 18.03.2015
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Our previous work demonstrates that DHX32 is upregulated in colorectal cancer (CRC) compared to its adjacent normal tissues. However, how overexpressed DHX32 contributes to CRC remains largely unknown. In this study, we reported that DHX32 was overexpressed in human colon cancer cells. Overexpressed DHX32 promoted SW480 cancer cells proliferation, migration and invasion, as well as decreased the susceptibility to chemotherapy agent 5-Fluorouracil. Furthermore, PCR array analyses revealed that depleting DHX32 in SW480 colon cancer cells suppressed expression of WISP1 , MMP7 and VEGFA in the Wnt pathway and anti-apoptotic gene BCL2 and CA9 , however, elevated expression of pro-apoptotic gene ACSL5. The findings suggested that overexpressed DHX32 played an important role in CRC progression and metastasis and that DHX32 has the potential to serve as a biomarker and a novel therapeutic target for CRC.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ISSN:2045-2322
2045-2322
DOI:10.1038/srep09247